|
1
|
Ministry of Health, Labor and Welfare:
Vital Statistics Japan. Ministry of Health, Labor and Welfare,
Tokyo, 2019. https://ganjoho.jp/reg_stat/statistics/dl/index.html#mortality
(In Japanese).
|
|
2
|
Hashiguchi Y, Muro K, Saito Y, Ito Y,
Ajioka Y, Hamaguchi T, Hasegawa K, Hotta K, Ishida H, Ishiguro M,
et al: Japanese society for cancer of the colon and rectum (JSCCR)
guidelines 2019 for the treatment of colorectal cancer. Int J Clin
Oncol. 25:1–42. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
WHO Classification of Tumours Editorial
Board: Digestive System Tumours: WHO Classification of Tumours.
IARC Publications, Lyon, 2019.
|
|
4
|
McGranahan N and Swanton C: Clonal
heterogeneity and tumor evolution: Past, present, and the future.
Cell. 168:613–628. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Mukai M, Kishima K, Fukumitsu H, Sekido Y,
Izumi H, Hoshikawa T, Tajima T, Tobita K, Sadahiro S, Yasuda S and
Ogoshi K: Is the T1/2N1 (≤3 nodes) category actually stage IIIA
(TNM)/IIIa (Japanese classification) in patients with primary
colorectal cancer? Oncol Rep. 26:209–214. 2011.PubMed/NCBI View Article : Google Scholar
|
|
6
|
World Health Organization (WHO):
International statistical classification of diseases and health
related problems. ICD-10. WHO, Geneva, 2013.
|
|
7
|
Japanese Society for Cancer of the Colon
and Rectum (JSCCR): Japanese Classification of Colorectal
Carcinoma. Kanehara & Co., Ltd., Tokyo, pp10-32, 2013.
|
|
8
|
National Comprehensive Cancer Network
(NCCN): NCCN clinical practice guidelines in oncology rectal
cancer. Version 3.2017. NCCN, Plymouth Meeting, PA, 2017.
|
|
9
|
National Comprehensive Cancer Network
(NCCN): NCCN clinical practice guidelines in oncology colon cancer.
Version 2.2017, 2017. NCCN, Plymouth Meeting, PA, 2017.
|
|
10
|
Tsakraklides V, Wanebo HJ, Sternberg SS,
Stearns M and Good RA: Prognostic evaluation of regional lymph node
morphology colorectal cancer. Am J Surg. 129:174–180.
1975.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Schofield JB, Mounter NA, Mallett R and
Haboubi NY: The importance of accurate pathological assessment of
lymph node involvement in colorectal cancer. Colorectal Dis.
8:460–470. 2006.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Shanmugam C, Hines RB, Jhala NC, Katkoori
VR, Zhang B, Posey JA Jr, Bumpers HL, Grizzle WE, Eltoum IE, Siegal
GP and Manne U: Evaluation of lymph node numbers for adequate
staging of stage II and III colon cancer. J Hematol Oncol.
4(25)2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Jiang K, Zhu Y, Liu Y, Ye Y, Xie Q, Yang X
and Wang S: Lymph node ratio as an independent prognostic indicator
in stage III colorectal cancer: especially for fewer than 12 lymph
nodes examined. Tumour Biol. 35:11685–11690. 2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Derwinger K, Carlsson G and Ekman T:
Defining stage III disease in colorectal cancer-aspects on
treatment and evaluation of survival. J Surg Oncol. 102:424–427.
2010.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wang LP, Wang HY, Cao R, Zhu C and Wu XZ:
Proposal of a new classification for stage III colorectal cancer
based on the number and ratio of metastatic lymph nodes. World J
Surg. 37:1094–1102. 2013.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wong KP, Poon JT, Fan JK and Law WL:
Prognostic value of lymph node ratio in stage III colorectal
cancer. Colorectal Dis. 13:1116–1122. 2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Basnet S, Lou QF, Liu N, Rana R, Shah A,
Khadka M, Warrier H, Sigdel S, Dhakal S, Devkota A, et al: Tumor
deposit is an independent prognostic indicator in patients who
underwent radical resection for colorectal cancer. J Cancer.
9:3979–3985. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Nagtegaal ID, Knijn N, Hugen N, Marshall
HC, Sugihara K, Tot T, Ueno H and Quirke P: Tumor deposits in
colorectal cancer: Improving the value of modern staging-a
systematic review and meta-analysis. J Clin Oncol. 35:1119–1127.
2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Nagayoshi K, Ueki T, Nishioka Y, Manabe T,
Mizuuchi Y, Hirahashi M, Oda Y and Tanaka M: Tumor deposit is a
poor prognostic indicator for patients who have stage II and III
colorectal cancer with fewer than 4 lymph node metastases but not
for those with 4 or more. Dis Colon Rectum. 57:467–474.
2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Laso CA, González JJ, Fresno F, Azcano E,
Sanz L and Navarrete F: Prognostic value of micrometastases in
esophageal and colorectal carcinoma (a clinical experience).
Hepatogastroenterology. 51:964–967. 2004.PubMed/NCBI
|
|
21
|
Mescoli C, Albertoni L, Pucciarelli S,
Giacomelli L, Russo VM, Fassan M, Nitti D and Rugge M: Isolated
tumor cells in regional lymph nodes as relapse predictors in stage
I and II colorectal cancer. J Clin Oncol. 30:965–971.
2012.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Onaka T, Tsunoda A, Watanabe M, Nakao K,
Takimoto M and Kusano M: The pathway of isolated tumor cells from
tumor budding in stage II colorectal cancer detected by
immunohistochemistry. Showa Univ J Med Sci. 21:25–36. 2009.
|
|
23
|
Lee MR, Hong CW, Yoon SN, Lim SB, Park KJ,
Lee MJ, Kim WH and Park JG: Isolated tumor cells in lymph nodes are
not a prognostic marker for patients with stage I and II colorectal
cancer. J Surg Oncol. 93:13–19. 2006.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Mukai M, Sato S, Komatsu N, Nishida T,
Shiba K, Ito I, Nakasaki H and Makuuchi H: Correlation between
occult neoplastic cells in the lymph node sinuses and recurrence in
patients with Dukes' C colorectal cancer. Oncol Rep. 10:1165–1169.
2003.PubMed/NCBI
|
|
25
|
Mukai M, Sato S, Komatsu N, Nishida T,
Shiba K, Ito I, Nakasaki H and Makuuchi H: Correlation between
occult neoplastic cells in the lymph node sinuses and recurrence in
patients with curatively resected Dukes' B colorectal cancer. Oncol
Rep. 10:1177–1181. 2003.PubMed/NCBI
|
|
26
|
Mukai M, Sato S, Nishida T, Komatsu N,
Shiba K, Nakasaki H and Makuuchi H: Selection criteria for high
risk and low risk groups of recurrence and metastasis in patients
with primary colorectal cancer. Oncol Rep. 10:1753–1758.
2003.PubMed/NCBI
|
|
27
|
Mukai M, Sato S, Nakasaki H, Tajima T,
Saito Y, Nishiumi N, Iwasaki M, Tokuda Y, Ogoshi K, Inoue H and
Makuuchi H: Occult neoplastic cells in the lymph node sinuses and
recurrence of primary breast, lung, esophageal, and gastric cancer.
Oncol Rep. 11:81–84. 2004.PubMed/NCBI
|
|
28
|
Mukai M: Occult neoplastic cells and
malignant micro-aggregates in lymph node sinuses: Review and
hypothesis. Oncol Rep. 14:173–175. 2005.PubMed/NCBI
|
|
29
|
Sekido Y, Mukai M, Kishima K, Tajima T,
Hoshikawa T, Nakamura M, Nakamura N and Ogoshi K: Occult neoplastic
cells in the lymph node sinuses and recurrence/metastasis of stage
II/Dukes' B colorectal cancer. Oncol Rep. 25:69–73. 2011.PubMed/NCBI
|
|
30
|
Sekido Y, Mukai M, Kishima K, Tajima T,
Hoshikawa T, Nakamura M, Nakamura N and Ogoshi K: Occult neoplastic
cells in the lymph node sinuses and recurrence/metastasis of stage
III/Dukes' C colorectal cancer. Oncol Rep. 25:915–919.
2011.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Nakamura Y, Mukai M, Hiraiwa S, Kishima K,
Sugiyama T, Tajiri T, Yamada S and Iwazaki M: Free-floating cancer
cells in lymph node sinuses of hilar lymph node-positive patients
with non-small cell lung cancer. Mol Med Rep. 18:1081–1087.
2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Romiti A, Roberto M, Marchetti P, Di Cerbo
A, Falcone R, Campisi G, Ferri M, Balducci G, Ramacciato G, Ruco L
and Pilozzi E: Study of histopathologic parameters to define the
prognosis of stage II colon cancer. Int J Colorectal Dis.
34:905–913. 2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Compton CC: Colorectal carcinoma:
Diagnostic, prognostic, and molecular features. Mod Pathol.
16:376–388. 2003.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Gunderson LL, Jessup JM, Sargent DJ,
Greene FL and Stewart A: Revised tumor and node categorization for
rectal cancer based on surveillance, epidemiology, and end results
and rectal pooled analysis outcomes. J Clin Oncol. 28:256–263.
2010.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Shankaran V, Ikeda H, Bruce AT, White JM,
Swanson PE, Old LJ and Schreiber RD: IFNgamma and lymphocytes
prevent primary tumour development and shape tumour immunogenicity.
Nature. 410:1107–11. 2001.PubMed/NCBI View
Article : Google Scholar
|
